Sarilumab
EFC18055
Approved small_molecule active
Quick answer
Sarilumab for Polymyalgia Rheumatica is a Approved program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Polymyalgia Rheumatica
- Phase
- Approved
- Modality
- small_molecule
- Status
- active